SRP-4053 (exon 53)
SKU:
THE0466
$0.00
per item
10-year Global therapeutic forecast for SRP-4053 (exon 53) indicated for Duchenne Muscular Dystrophy.
(The treatment of Duchenne muscular dystrophy in patients with a deletion, duplication or frame shift mutation correctable by skipping of exon 50 of the dystrophin gene to allow restoration of the reading frame (including mutations within exons 51, 51-53, or 51-55).)
Forecasts are provided by country with sources/methodology explanation. Additional countries can be line-itemed by request. Pricing assumptions, access assumptions, epi literature PDFs and other source files will be provided in addition to the forecast.
SUBSCRIBERS: Click Buy Now and your subscription will be recognized by your email address.
NON-SUBSCRIBERS: Click Buy Now and enter your contact information to set up a consultation or to request one free standard report for first-time customers. No payment information is required. We will contact you within 12 hours.
ADVANCED patient subtyping and landscape analyses are also available, as well as KOL research and other approaches. For advanced analyses, begin by requesting this standard therapeutic forecast (click Buy Now) and we will contact you within 12 hours. Alternately, directly contact [email protected] (or your account manager) to connect on needs and timing.
(The treatment of Duchenne muscular dystrophy in patients with a deletion, duplication or frame shift mutation correctable by skipping of exon 50 of the dystrophin gene to allow restoration of the reading frame (including mutations within exons 51, 51-53, or 51-55).)
Forecasts are provided by country with sources/methodology explanation. Additional countries can be line-itemed by request. Pricing assumptions, access assumptions, epi literature PDFs and other source files will be provided in addition to the forecast.
SUBSCRIBERS: Click Buy Now and your subscription will be recognized by your email address.
NON-SUBSCRIBERS: Click Buy Now and enter your contact information to set up a consultation or to request one free standard report for first-time customers. No payment information is required. We will contact you within 12 hours.
ADVANCED patient subtyping and landscape analyses are also available, as well as KOL research and other approaches. For advanced analyses, begin by requesting this standard therapeutic forecast (click Buy Now) and we will contact you within 12 hours. Alternately, directly contact [email protected] (or your account manager) to connect on needs and timing.